I’m fascinated by these sorts of stories. A terrible, crippling, life-altering disease could – potentially – be treated with…nasal drops.
“[R]esearchers from Karolinska Institute in Sweden and LSU Health New Orleans have released a study that suggests a comparatively simple way of investigating inflammation’s effect on AD and possibly treating it.
The study’s authors successfully halted memory loss in mice with AD with the noninvasive, intranasal delivery of a compound known to resolve neuroinflammation.”
The drops in question help lower neuroinflammation, which is widely seen now as one of the major causes of neurodegenerative disease, including Alzheimer’s, Parkinson’s, and Lewy Body Dementia (LBD).
The usual caveats apply: this study was conducted on lab animals, not people. Human trials are years away, and any potential therapeutic drugs are likely a decade or more – at best – from being available. But any good news is cause for celebration in this field.
Brought to you by smpltec.com, Technology for Seniors News.